Jushi Holdings (JUSHF) Return on Capital Employed (2022 - 2026)
Jushi Holdings' (JUSHF) quarterly Return on Capital Employed came in at 2.35% in Q1 2026, up 105.0% year-on-year from 1.15% in Q1 2025, and up 74.68% on a QoQ basis from 1.34% in Q4 2025.
Jushi Holdings (JUSHF) Return on Capital Employed (2022 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 5 years of Return on Capital Employed data on file, last reported at 2.35% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 105.0% year-over-year to 2.35% in Q1 2026; TTM through Mar 2026 was 2.35%, a 105.0% increase from a year earlier, with the FY2025 full-year figure at 1.33%, down 151.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 2.35%, up from 1.34% in the prior quarter.
- Over the last five years, Return on Capital Employed for JUSHF reached as high as 2.92% in Q4 2024 and fell as low as 49.89% in Q1 2023.
- Historically, Return on Capital Employed has averaged 12.57% across 5 years, with a median of 0.35% in 2025.
- Across the five-year window, Return on Capital Employed plunged 3827 bps in 2023 and jumped 5157 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 44.91% in 2022, then soared by 98 bps to 0.9% in 2023, then surged by 425 bps to 2.92% in 2024, then tumbled by 54 bps to 1.34% in 2025, then jumped by 75 bps to 2.35% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 2.35% in Q1 2026, 1.34% in Q4 2025, and 0.69% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 2.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35% |
| Dec 31, 2025 | 1.34% |
| Sep 30, 2025 | 0.69% |
| Jun 30, 2025 | 0.02% |
| Mar 31, 2025 | 1.29% |
| Dec 31, 2024 | 2.92% |
| Sep 30, 2024 | 1.63% |
| Jun 30, 2024 | 2.30% |
| Mar 31, 2024 | 1.29% |
| Dec 31, 2023 | -0.90% |
| Sep 30, 2023 | -35.77% |
| Jun 30, 2023 | -49.27% |
| Mar 31, 2023 | -49.89% |
| Dec 31, 2022 | -44.91% |
| Sep 30, 2022 | -23.24% |
| Jun 30, 2022 | -11.00% |